Management of stable angina

A Jain1, V Wadehra, A D Timmis

  • 1London Chest Hospital, London, UK. ajay106@hotmail.com

Insights

Managing chronic stable angina involves treating co-existing conditions, modifying risk factors, and relieving symptoms. While lifestyle changes and certain medications offer proven benefits, optimal strategies for risk stratification and treatment remain under investigation for ischemic heart disease.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • Ischemic heart disease, encompassing conditions like angina pectoris and myocardial infarction, presents a significant health burden.
  • Chronic stable angina is a prevalent condition affecting individuals and society, necessitating effective management strategies.

Purpose of the Study:

  • To outline the multifaceted goals in managing chronic stable angina.
  • To review current understanding and evidence gaps in risk stratification and treatment strategies for angina.
  • To emphasize the importance of lifestyle modifications and evidence-based therapies.

Main Methods:

  • Review of existing literature on the management of ischemic heart disease and chronic stable angina.
  • Analysis of the evidence base for various therapeutic interventions, including lifestyle modifications, pharmacotherapy, angioplasty, and coronary artery bypass surgery.
  • Assessment of risk stratification methods and their limitations.

Main Results:

  • Lifestyle modification and attention to modifiable risk factors are paramount for improving outcomes.
  • Lipid-lowering treatment and antiplatelet therapy demonstrate proven mortality benefits.
  • Angioplasty offers symptomatic relief but no mortality benefit, whereas coronary artery bypass surgery reduces mortality in severe coronary disease.

Conclusions:

  • Optimal treatment strategies for chronic stable angina require further clarification, particularly regarding risk stratification.
  • Evidence for anti-anginal therapies is less robust than for therapies improving overall outcome.
  • Coronary artery bypass surgery is indicated for mortality reduction in specific patient populations with severe coronary artery disease.

Related Concept Videos

Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...